GlobeNewswire by notified

Better Collective acquires Canada Sports Betting

Share

Regulatory Release 15/2022
                                                                                                                                                                     March 23, 2022


With the acquisition of Canada Sports Betting, Better Collective makes a strong entry to the Canadian market just before the largest province of Ontario launches online sports betting in April 2022. In connection, Better Collective is updating its Financial Targets for the financial year 2022.

Sports betting media group, Better Collective, announces that it has on March 23, 2022  acquired the assets of  Canada Sports Betting (‘CSB’), for a maximum purchase price of 21.4 mEUR (23.5 mUSD). Better Collective expects that the Canadian activities will generate revenue in excess of 5 mEUR during the financial year 2022. CSB was launched with an ambition to guide sports fans to wagering websites that will suit their betting needs and has become an established sports betting brand with a solid position in the market by helping their users make informed online betting decisions.

The province of Ontario, with a population of approx. 15 million people and a GDP that would place them as the 6th largest state in a US setting, has already granted licenses to multiple commercial operators. The launch of online sports betting in Ontario will take place on April 4, 2022, and a number of other provinces throughout Canada are expected to take steps to regulate their online sports betting markets in the near future.

The Transaction
The purchase price amounts to  a maximum of 21.4 mEUR (23.5 mUSD), of which 15.9 mEUR is an upfront cash payment and 5.5 mEUR is a deferred cash payment contingent on certain deliverables within three months. Better Collective has recently expanded its credit lines with Nordea Bank by 100 mEUR to finance further acquisitions, including the CSB assets.

Better Collective in North America

Following the execution of Better Collective’s acquisition strategy and ongoing investments in the North American sports betting market, Better Collective’s US business has developed successfully, with high growth and a rapid increase in profitability. The acquisition of CSB underlines Better Collective’s intention to achieve a leading position as an online sports betting media in Canada. This will be enabled by a number of strong product offerings from existing brands, including Action Network and VegasInsider and the newly acquired CSB.  In the light of this, Better Collective expects the North American market to continue growing with increasing revenue and operational earnings.

Jesper Søgaard, CEO of Better Collective, says:

“I am very happy to include Canada Sports Betting in the Better Collective product portfolio. This acquisition gives us a strong foothold in a Canadian market, which is developing in a very promising direction. With these new websites and with support from our established North American business, I believe we can develop these assets to become flagship brands within sports betting in Canada. ”

Financial targets 2022 update
In connection with the acquisition of CSB, Better Collective updates its financial targets for the financial year 2022. Operational earnings (EBITDA) is now expected to reach approximately 80 mEUR (previously approximately 75 mEUR). Other financial targets relating to organic growth and debt leverage remain unchanged. The updated financial targets reflect the expected earnings from the Canadian market and a generally strong business performance in the first months of the year. 


Enquiries regarding this press release should be addressed to:

Investor contact: Christina Bastius Thomsen, +45 2363 8844 Investor@bettercollective.com

Media contact: Ulrik Marschall, +45 6068 6370, press@bettercollective.com


This information is such information as Better Collective A/S is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above on March 23, 2022 at 6.20 pm CET.



About Better Collective

Better Collective is a global sports betting media group providing platforms that empower and enhance the betting experience for sports fans and iGamers. Aiming to make betting and gambling more entertaining, transparent and fair, Better Collective offers a range of editorial content, bookmaker information, data insights, betting tips, iGaming communities and educational tools. Its portfolio of websites include bettingexpert.com, VegasInsider.com, HLTV.org and Action Network. Better Collective is headquartered in Copenhagen, Denmark, and listed on Nasdaq Stockholm (BETCO). More information at bettercollective.com.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Changes in financial results publication18.5.2022 18:01:16 CEST | Press release

PRFoods AS declares that 2021/2022 financial year 9 months unaudited results will be published, according to Stock Exchange rules no later than two months after end of the reporting period, 31.5.2022. Although interim report will be unaudited, PRFoods has required a third party assessment of the impact of sale of Heimon Kala Oy, taking into account that final purchase price is dependent on certain conditions subsequent presumed to be met before publication. Indrek Kasela AS PRFoods Member of the Management Board Phone: +372 452 1470 investor@prfoods.ee www.prfoods.ee

PRESS RELEASE: NACON: WRC GENERATIONS: THE MOST COMPLETE RALLY GAME IS COMING IN OCTOBER!18.5.2022 17:46:00 CEST | Press release

WRC GENERATIONS: THE MOST COMPLETE RALLY GAME IS COMING IN OCTOBER! Lesquin, 18th May 2022 - NACON and the studio KT Racing are pleased to announce their new rally game, WRC Generations, the official video game of the FIA World Rally Championship, scheduled for release in Autumn 2022 on PlayStation®4, PlayStation®5, Xbox One, Xbox Series X|S, Nintendo Switch and Steam for PC. The result of 7 years of collaboration with legendary drivers, who have already made WRC 10 and WRC 9 the references of the genre, the latest entry in the series is an authentic and comprehensive rally racing simulation, giving players the chance to drive powerful cars in the most famous rallies of all time! Check out the announcement trailer for WRC Generations: [link] An unrivalled level of realism Never before have games come this close to the real-life World Rally Championship! Hailed by both critics and professionals, this year's WRC simulation has been reinforced with numerous improvements and optimisations

PRESS RELEASE: NACON PRESENTS AN AMBITIOUS LINEUP AND ANNOUNCES TWO NEW GAMES18.5.2022 17:45:00 CEST | Press release

NACON PRESENTS AN AMBITIOUS LINEUP AND ANNOUNCES TWO NEW GAMES NACON has confirmed its status as a major mid-publisher and creator of standard-setting accessories Paris (France), 18 May 2022 – The latest edition of Bigben Week opened its doors on Monday. This major event for the group is the perfect occasion to present its products and objectives to the media and international partners. NACON, the group's gaming brand, held a press conference to announce all of its news and to explain how it is changing. The last time the event was held – in 2019, due to the health crisis – BIGBEN presented its soaring ambitions for the years to come. Bigben Week is an opportunity to highlight the company's strong growth over the last three years along with the major changes it has undergone. AN EFFECTIVE STRATEGY NACON’s March 2020 listing on the stock market raised more than €100 million, reinforcing the company's ambitions and resources. Over the course of three years, NACON acquired no fewer than 9

FDA beviljar särläkemedelsstatus för tasquinimod vid behandling av myelofibros18.5.2022 15:00:00 CEST | Pressemelding

Lund 18 maj 2022 - Active Biotech AB (Nasdaq Stockholm: ACTI) meddelade idag att amerikanska Food and Drug Administration (FDA) har beviljat särläkemedelsstatus för tasquinimod vid behandling av myelofibros. "Särläkemedelsstatus som FDA tilldelat för tasquinimod i myelofibros utgör ett viktigt steg framåt för Active Biotech", säger Helén Tuvesson, VD Active Biotech. "Det öppnar en viktig regulatorisk väg och ger oss potential att snabbt avancera utvecklingen av tasquinimod i denna patientpopulation.” FDAs Orphan Drug Designation program ger särläkemedelsstatus för läkemedelskandidater avsedda för säker och effektiv behandling, diagnos eller förebyggande av ovanliga sjukdomar som drabbar färre än 200.000 människor i USA. Denna särläkemedelsstatus ger 7 års marknadsexklusivitet vid marknadsgodkännande samt vissa andra fördelar. I februari 2022 ingick Active Biotech ett exklusivt licensavtal med Oncode Institute i Nederländerna, som verkar på uppdrag av Erasmus University Medical Center (

FDA grants Orphan Drug Designation for tasquinimod in myelofibrosis18.5.2022 15:00:00 CEST | Press release

Lund May 18, 2022 - Active Biotech AB (Nasdaq Stockholm: ACTI) today announced that the U.S. Food and Drug Administration (FDA) has granted tasquinimod Orphan Drug Designation for the treatment of myelofibrosis. “The Orphan Drug Designation awarded by the FDA for tasquinimod in myelofibrosis represents an important step forward for Active Biotech”, said Helén Tuvesson, CEO Active Biotech. “It opens an important regulatory pathway and provides us with the potential to rapidly advance the development of tasquinimod in this patient population.” The FDA Orphan Drug Designation program provides orphan status to drugs and biologics which are defined as those intended for the safe and effective treatment, diagnoses or prevention of rare diseases or disorders that affects fewer than 200,000 people in the U.S. This designation provides for a seven-year marketing exclusivity period against competition, as well as certain incentives. In February 2022, Active Biotech entered into an exclusive lice